Are we ready to use TMB in breast cancer clinical practice? Sara RavaioliFrancesco LimarziSara Bravaccini Editorial 28 July 2020 Pages: 1943 - 1945
Economic evaluations of cancer immunotherapy: a systematic review and quality evaluation Charlotte CouchoudPhilippe FagnoniVirginie Nerich Review 16 July 2020 Pages: 1947 - 1958
Therapeutic ISCOMATRIX™ adjuvant vaccine elicits effective anti-tumor immunity in the TRAMP-C1 mouse model of prostate cancer Adele M. BarrAnabel SilvaAdriana Baz Morelli Original Article 09 May 2020 Pages: 1959 - 1972
Activated HIF1α of tumor cells promotes chemoresistance development via recruiting GDF15-producing tumor-associated macrophages in gastric cancer Shan YuQian LiFenglin Liu Original Article 09 May 2020 Pages: 1973 - 1987
Expression of immune checkpoints and T cell exhaustion markers in early and advanced stages of colorectal cancer Reem SalehRowaida Z. TahaEyad Elkord Original Article Open access 11 May 2020 Pages: 1989 - 1999
Integrity of plasma DNA is inversely correlated with vaccine-induced antitumor immunity in ovarian cancer patients Kayoko WakiKanako YokomizoAkira Yamada Original Article Open access 11 May 2020 Pages: 2001 - 2007
The effects of tumor resection and adjuvant therapy on the peripheral blood immune cell profile in patients with colon carcinoma Daniëlle KrijgsmanNatasja L. De VriesMarianne Hokland Original Article Open access 12 May 2020 Pages: 2009 - 2020
Prevention of liver metastases through perioperative acute CpG-C immune stimulation Liat SorskiRivka MelamedShamgar Ben-Eliyahu Original Article 13 May 2020 Pages: 2021 - 2031
Successful treatment of steroid-refractory immune checkpoint inhibitor-related pneumonitis with triple combination therapy: a case report Hirofumi UtsumiJun ArayaKazuyoshi Kuwano Original Article 15 May 2020 Pages: 2033 - 2039
Galectin-9 expression as a poor prognostic factor in patients with renal cell carcinoma Ryosuke JikuyaTakeshi KishidaTetsuro Sasada Original Article 18 May 2020 Pages: 2041 - 2051
Expression of programmed death-ligand 1 (PD-L1) in human pituitary neuroendocrine tumor Valentine SuteauAlexandre CollinClaire Briet Original Article 22 May 2020 Pages: 2053 - 2061
Primary breast tumours but not lung metastases induce protective anti-tumour immune responses after Treg-depletion Ellyn HughesSarah N. LauderAwen Gallimore Original Article Open access 23 May 2020 Pages: 2063 - 2073
Immune checkpoint inhibitors reverse tolerogenic mechanisms induced by melanoma targeted radionuclide therapy Jacques RouanetValentin BenboubkerPaul-Olivier Rouzaire Original Article 23 May 2020 Pages: 2075 - 2088
PD-L1 expression correlates with tumor-infiltrating lymphocytes and better prognosis in patients with HPV-negative head and neck squamous cell carcinomas Mario Sanchez-CanteliRocio Granda-DíazJuan P. Rodrigo Original Article 24 May 2020 Pages: 2089 - 2100
Systemic but not MDSC-specific IRF4 deficiency promotes an immunosuppressed tumor microenvironment in a murine pancreatic cancer model Philipp MetzgerSabrina V. KirchleitnerLars M. König Original Article Open access 24 May 2020 Pages: 2101 - 2112
A TLR4–TRIF-dependent signaling pathway is required for protective natural tumor-reactive IgM production by B1 cells Allison M. DyevoichNataya S. DisherKaren M. Haas Original Article 24 May 2020 Pages: 2113 - 2124
Development of CDX-527: a bispecific antibody combining PD-1 blockade and CD27 costimulation for cancer immunotherapy Laura A. VitaleLi-Zhen HeTibor Keler Original Article Open access 25 May 2020 Pages: 2125 - 2137
Antitumor efficacy of BAFF-R targeting CAR T cells manufactured under clinic-ready conditions Zhenyuan DongWesley A. ChengHong Qin Original Article Open access 25 May 2020 Pages: 2139 - 2145
NKG2D-Fc fusion protein promotes antitumor immunity through the depletion of immunosuppressive cells Po-Hao FengBrandon LamChien-Fu Hung Original Article 28 May 2020 Pages: 2147 - 2155
Sex differences in the association between tumor growth and T cell response in a melanoma mouse model Panshak P. DakupKenneth I. PorterShobhan Gaddameedhi Research Report 25 June 2020 Pages: 2157 - 2162
Observations on neuroimmunomodulation as a novel therapeutic strategy in metastasis Ashwin Kumaria Letter to the Editors 07 July 2020 Pages: 2163 - 2164